This study could not detect an effect of recombinant TFPI (i.e. Tifacogin) on mortality in the primary study population, i.e. patients with severe sepsis and international normalized ratio (INR) ≥ 1.2, but an increased rate of bleeding8. This evidence concerns the gene TFPI and Sepsis.